Abstract
Activated ras is known to dysregulate TGF-β signaling by altering the expression of TGF-β type II receptor (RII). It is well documented that tumor cells harboring mutant ras are more resistant to radiation than cells with wild-type ras. In this study, we hypothesized that the use of farnesyltransferase inhibitor (FTI, L-744,832) may directly restore TGF-β signaling through RII expression via ras dependent or independent pathway leading to induction of radiation sensitivity. Two pancreatic cancer cell lines, BxPC-3 and MIA PaCa-2 were used in this study. FTI inhibited farnesylation of Ras protein more significantly in MIA PaCa-2 than BxPC-3 cells. In contrast, MIA PaCa-2 cells were resistant to radiation when compared to BxPC-3 cells. BxPC-3 cells were more resistant to FTI than MIA PaCa-2 cells. In combination treatment, no significant radiosensitizing effect of FTI was observed in BxPC-3 cells at 5 or 10 μM. However, in MIA PaCa-2 cells, a significant radiosensitizing effect was observed at both 5 and 10 μM concentrations (P>0.004). The TGF-β effector gene p21waf1/cip1 was elevated in combination treatment in MIA PaCa-2 but not in BxPC-3 cells. In MIA PaCa-2 cells, FTI induced TGF-β responsive promoter activity as assessed by 3TP-luciferase activity. A further induction of luciferase activity was observed in MIA PaCa-2 cells treated with radiation and FTI. Induction of TGF-β signaling by FTI was mediated through restoration of the RII expression, as demonstrated by RT–PCR analysis. In addition, re-expression of RII by FTI was associated with a decrease in DNA methyltransferase 1 (DNMT1) levels. Thus, these findings suggest that the L-744,832 treatment restores the RII expression through inhibition of DNMT1 levels causing induction of TGF-β signaling by radiation and this forms a novel molecular mechanism of radiosensitization by FTI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adnane J, Bizouarn FA, Chen Z, Ohkanda J, Hamilton AD, Munoz-Antonia T, Sebti SM . 2000 Oncogene 19: 5525–5533
Ahmed MM, Alcock RA, Chendil D, Dey S, Das A, Venkatasubbarao K, Mohiuddin M, Sun L, Strodel WE, Freeman JW . 2002 J. Biol. Chem. 277: 2234–2246
Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, Rangnekar VM . 1997 J. Biol. Chem. 272: 33056–33061
Alexandrow MG, Moses HL . 1995 Cancer Res. 55: 1452–1457
Bae HW, Geiser AG, Kim D, Chung MT, Burmester JK, Sporn MB, Roberts AB, Kim SJ . 1995 J. Biol. Chem. 270: 29460–29468
Basolo F, Fiore L, Ciardiello F, Calvo S, Fontanini G, Conaldi PG, Toniolo A . 1994 Int. J. Cancer 56: 736–742
Bernhard EJ, Stanbridge EJ, Gupta S, Gupta AK, Soto D, Bakanauskas VJ, Cerniglia GJ, Muschel RJ, McKenna WG . 2000 Cancer Res. 60: 6597–6600
Bigey P, Ramchandani S, Theberge J, Araujo FD, Szyf M . 2000 Gene 242: 407–418
Bruyneel EA, Storme GA, Schallier DC, Van den Berge DL, Hilgard P, Mareel MM . 1993 Eur. J. Cancer 29A: 1958–1963
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE . 1994 Nat. Genet. 8: 27–32
Calonge MJ, Massague J . 1999 J. Biol. Chem. 274: 33637–33643
Cui W, Fowlis D, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ . 1996 Cell 86: 531–542
el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y . 1994 Cancer Res. 54: 1169–1174
el-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB . 1991 Proc. Natl. Acad. Sci. USA 88: 3470–3474
Filmus J, Zhao J, Buick RN . 1992 Oncogene 7: 521–526
Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin Jr AS . 1997 J. Biol. Chem. 272: 24113–24116
Fralix KD, Ahmed MM, Mattingly C, Swiderski C, McGrath PC, Venkatasubbarao K, Kamada N, Mohiuddin M, Strodel WE, Freeman JW . 2000 Cancer 88: 2010–2021
Freeman JW, Mattingly CA, Strodel WE . 1995 J. Cell Physiol. 165: 155–163
Galang CK, Der CJ, Hauser CA . 1994 Oncogene 9: 2913–2921
Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S . 1999 Cancer Res. 59: 320–324
Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ, McKenna WG . 2001 Cancer Res. 61: 4278–4282
Gupta AK, Bernhard EJ, Bakanauskas VJ, Wu J, Muschel RJ, McKenna WG . 2000 Radiat. Res. 154: 64–72
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE . 1996 Science 271: 350–353
Hermens AF, Bentvelzen PA . 1992 Cancer Res. 52: 3073–3082
Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Motoo Y, Okai T, Sawabu N . 1998 Clin. Cancer Res. 4: 1147–1152
Joshi-Barve SS, Rangnekar VV, Sells SF, Rangnekar VM . 1993 J. Biol. Chem. 268: 18018–18029
Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ . 1992 Proc. Natl. Acad. Sci. USA 89: 6403–6407
Kautiainen TL, Jones PA . 1986 J. Biol. Chem. 261: 1594–1598
Leach SD, Berger D, Davidson BS, Curley SA, Tainsky MA . 1998 Pancreas 16: 491–498
MacLeod AR, Rouleau J, Szyf M . 1995 J. Biol. Chem. 270: 11327–11337
MacLeod AR, Szyf M . 1995 J. Biol. Chem. 270: 8037–8043
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B . 1995 Science 268: 1336–1338
Marte BM, Downward J . 1997 Trends Biochem. Sci. 22: 355–358
Massague J . 1990 Annu. Rev. Cell Biol. 6: 597–641
Miller AC, Kariko K, Myers CE, Clark EP, Samid D . 1993 Int. J. Cancer 53: 302–307
Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM . 1999 J. Biol. Chem. 274: 29976–29983
Reiss M, Barcellos-Hoff MH . 1997 Breast Cancer Res. Treat. 45: 81–95
Rouleau J, MacLeod AR, Szyf M . 1995 J. Biol. Chem. 270: 1595–1601
Saha D, Datta PK, Beauchamp RD . 2001 J. Biol. Chem. 276: 29531–29537
Sells SF, Muthukumar S, Sukhatme VP, Crist SA, Rangnekar VM . 1995 Mol. Cell. Biol. 15: 682–692
Shichinohe T, Senmaru N, Furuuchi K, Ogiso Y, Ishikura H, Yoshiki T, Takahashi T, Kato H, Kuzumaki N . 1996 J. Surg. Res. 66: 125–130
Simeone DM, Pham T, Logsdon CD . 2000 Ann. Surg. 232: 73–80
Song SY, Meszoely IM, Coffey RJ, Pietenpol JA, Leach SD . 2000 Neoplasia 2: 261–272
Sporn MB, Roberts AB . 1990 Ann. NY Acad. Sci. 593: 1–6
Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower Jr WR, Salhab KF, McGrath P, Strodel W, Freeman JW . 2000 Anticancer Res. 20: 43–51
Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW . 2001 Cancer Res. 61: 6239–6247
Wrana JL, Attisano L, Wieser R, Ventura F, Massague J . 1994 Nature 370: 341–347
Zhao J, Buick RN . 1995 Cancer Res. 55: 6181–6188
Acknowledgements
This work is supported by a grant from NCI 1 R01 CA86937, to MM Ahmed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alcock, R., Dey, S., Chendil, D. et al. Farnesyltransferase inhibitor (L-744,832) restores TGF-β type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene 21, 7883–7890 (2002). https://doi.org/10.1038/sj.onc.1205948
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205948
Keywords
This article is cited by
-
Post-translational modification of KRAS: potential targets for cancer therapy
Acta Pharmacologica Sinica (2021)
-
Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer
Scientific Reports (2017)
-
Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice
Cell Death & Disease (2014)
-
The Epigenetics of Gastrointestinal Malignancies
Current Colorectal Cancer Reports (2012)
-
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
Breast Cancer Research (2004)